Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk ASfiledCriticalNovo Nordisk AS
Priority to CA 2058785priorityCriticalpatent/CA2058785C/en
Publication of CA2058785A1publicationCriticalpatent/CA2058785A1/en
Application grantedgrantedCritical
Publication of CA2058785CpublicationCriticalpatent/CA2058785C/en
In a process for producing proteins with FVIII activity and FVIII derivatives by in vitro culturing of mammalian cells, the culturing is carried out at temperatures below 32°C and the culturing times used are below 24 hours.
CA 20587851992-01-061992-01-06Method of producing proteins with fviii activity and/or fviii derivatives
Expired - LifetimeCA2058785C
(en)